SCHEMBL7096567

SCHEMBL7096567

CC(=O)OC(=O)c1ccc(F)c(F)c1F

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 6/20 0.57
CES1 P23141 6/20 0.57
ITGB1 P05556 1/20 0.43
ITGA5 P08648 1/20 0.43
BCHE P06276 1/20 0.36
CYP4F2 P78329 1/20 0.35
CYP4A11 Q02928 1/20 0.35
ALDH1A1 P00352 2/20 0.35
TSHR P16473 1/20 0.35
HSD17B10 Q99714 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
KMT2A Q03164 1/20 0.33
NPC1 O15118 2/20 0.33
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
RAB9A P51151 2/20 0.32
POLB P06746 1/20 0.32
HTT P42858 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5255903 0.88 CES2 (0.44) CES2CES1ITGB1ITGA5TDP1
SCHEMBL5277970 0.80 ITGB1 (0.40) CES2CES1ITGB1ITGA5CYP4F2
SCHEMBL382348 0.79 CES2 (0.61) CES2CES1ALDH1A1TSHRHSD17B10
SCHEMBL671906 0.79 CES2 (0.67) CES2CES1BCHEALDH1A1KMT2A
SCHEMBL30954397 0.79 CES2 (0.67) CES2CES1BCHEALDH1A1KMT2A
SCHEMBL29775631 0.79 CES2 (0.67) CES2CES1BCHEALDH1A1KMT2A
SCHEMBL1345183 0.79 CES2 (0.67) CES2CES1BCHEALDH1A1KMT2A
SCHEMBL28499259 0.77 CES2 (0.48) CES2CES1ALDH1A1
SCHEMBL5800869 0.76 CES2 (0.54) CES2CES1ITGB1ITGA5ALDH1A1
SCHEMBL28637523 0.76 CES2 (0.52) CES2CES1BCHEALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1313708-A1 QUINOLINE ANTIBACTERIAL COMPOUNDS AND METHODS OF USE THEREOF CHIRON CORPORATION (US) 2003-05-28 EP disclosed
WO-2002018345-A1 QUINOLINE ANTIBACTERIAL COMPOUNDS AND METHODS OF USE THEREOF CHIRON CORPORATION (US) 2002-03-07 WO disclosed